1.Discussion about treatment of severe acute respiratory syndrome based on syndrome differentiation
Dexin YAN ; Xiaoping YU ; Kehua SHI ; Wenbao SONG ; Huiyong ZHANG ; Jianglei WEI
Journal of Integrative Medicine 2004;2(4):241-4
Severe acute respiratory syndrome is an infectious disease caused by a new type of coronavirus. It belongs to the seasonal febrile diseases in traditional Chinese medicine. The prevention and treatment of severe acute respiratory syndrome (SARS) can be under the guidance of the doctrines for treating febrile diseases of traditional Chinese medicine, treatment based on syndrome differentiation, such as syndrome differentiation of triple energizer, syndrome differentiation according to defensive phase, qi phase, nutrient phase and blood phase. During April and May of 2003, 8 cases of SARS were diagnosed in Shanghai, and 6 patients accepted complementary therapy of traditional Chinese medicine, without death case. The only one patient who didn't take glucocorticoid therapy was complementarily treated with traditional Chinese herbs through the whole treating procedure. Upon the successful treatment of the eight cases of SARS in Shanghai, it is demonstrated that the triple-energizer syndrome differentiation and defensive-qi-nutrient-blood syndrome differentiation in traditional Chinese medicine are of high value in treating SARS patients.
2.Sero-prevalence of antibodies against avian influenza virus among people in poultry occupations in Guangdong province
Jie WU ; Hanzhong NI ; Lirong ZOU ; Yingchao SONG ; Laiqing LI ; Wenbao QI ; Min KANG ; Lijun LIANG ; Xin ZHANG ; Haojie ZHONG ; Guofeng HUANG ; Jinyan LIN ; Ming LIAO ; Changwen KE
Chinese Journal of Microbiology and Immunology 2015;(2):94-98
Objective To detect the positive rates of antibodies against avian influenza virus (AIV) subtypes H5, H6, H7 and H9 among people in poultry occupations in Guangdong province and to analyze the transmission of various subtypes of AIV from poultry to human contacts for the prevention and control of novel AIV infection in human beings.Methods Serum specimens were collected from 1066 peo-ple in poultry occupations ( occupational group) and 205 people not in poultry occupations ( non-occupational group) in 10 cities of Guangdong province.The inactivated AIV strains, isolated from poultry or environment of Guangdong province, were used as antigens to detect antibodies against AIV subtypes H5, H6, H7 and H9 by using the hemagglutination inhibition ( HI) assay.Results The positive rates of antibodies against AIV subtypes H5, H6, H7 and H9 carried by people from the occupational group were respectively 0.44%, 0%, 0.30%and 0.30%in 2013 and 1.08%, 0.0%, 0.0%and 0.27%in 2014.Only the anti-H9 anti-bodies were detected in serum samples collected form people in the non-occupational group in 2013 with a positive rate of 0.95%.No significant differences with the positive rates of anti-AIV antibodies were found between the occupational group and the non-occupational group.However, the geometric mean titer ( GMT) of anti-AVI antibodies in people from the occupational group was higher than that of the non-occupational group.Conclusion Although a grand spread of AIV from avian to human is not likely to happen yet, con-tacting with poultry is the risk factor for AIV infection in Guangdong population.A long-term surveillance of anti-AIV antibodies in serum should be strengthened among people in poultry occupations for the timely pre-vention and control of novel AIV outbreak.
3.Prevalence rate of ovine hepatic cystic echinococcosis in Quaker Wusu area of Bayinbuluke of Xinjiang, 2014
Jian DONG ; Lingfei YANG ; Wenbao ZHANG ; Haitao LI ; Tao JIANG ; Xinwei QI ; Tao SONG
Chinese Journal of Epidemiology 2015;36(2):136-138
Objective To investigate the prevalence rate of ovine hepatic cystic echinococcosis (HCE) in sheep in Quaker Wusu area of Bayinbuluke of Xinjiang by ultrasonography and provide evidence for the prevention and control of HCE in sheep.Methods The prevalence screening of HCE in sheep was conducted based on ultrasound images in this area in July 2014.The sheep were divided into different groups by dental age to calculate the age specific prevalence rate of HCE and analyzed the correlation between the dental age and the prevalence rate.Results The total prevalence rate of HCE in sheep in this area was 36.9%.The prevalence rates of none-calcified HCE and calcified HCE were 7.3% and 29.6%,respectively.The prevalence rates of none-calcified HCE in different age groups were 1.2% (1-2 years old),1.4% (2-3 years old),14.0% (3-4 years old),10.0% (4-5 years old),15.6%(5-6 years old) and 4.2%(>6 years old) respectively.The prevalence rate of calcified HCE in different age groups were 9.9%(1-2 years old),16.2% (2-3 years old),31.6%(3-4 years old),47.8%(4-5 years old),42.2%(5-6 years old) and 41.7%(>6 years old) respectively.The prevalence rate of HCE in 1-2 years old group was lower than those in other groups,the prevalence rate of HCE in age groups >3 years increased significantly.There was positive correlation between the prevalence rate of HCE and dental age (r=0.372,R2=0.107,F=44.176,P=0.000).Conclusion HCE is highly endemic in Quaker Wusu area.The prevalence rate of HCE is low in sheep with young age and high in sheep aged 3-4 years.It is necessary to conduct early prevention of HCE in sheep in this area.
4.Improvement Effects of Chelidonine on CCl 4-induced Hepatic Fibrosis Model Rats and Its Mechanism
Xiaoming LI ; Wenbao WANG ; Lina GUO ; Bo SONG ; Wei DONG ; Tianjiao XU ; Xiaoli WANG
China Pharmacy 2021;32(23):2868-2874
OBJECTIVE:To study the improvement eff ects and p otential mechanism of chelidonine on CCl 4-induced hepatic fibrosis model rats. METHODS :According to the random number table method ,a total of 48 rats were randomly divided into normal control group ,model group ,chelidonine low-dose ,middle-dose and high-dose groups (0.125,0.25,0.50 mg/kg),positive control group (Liver-protecting tablet ,0.42 g/kg),with 8 rats in each group. Except for normal control group ,other groups were given CCl 4-olive oil solution intraperitoneally for 8 weeks to induce hepatic fibrosis model. From the fifth week of modeling , normal control group and model group were given water intragastrically ;administration groups were given relevant medicine intragastrically,once a day ,for consecutive 10 weeks. After last intragastric administration ,hepatic index of rats was calculated. The levels of aspartate aminotransferase (AST),alanine aminotransferase (ALT)and hyaluronic acid (HA)in serum and the level of hydroxyproline (Hyp)in liver tissue were determined. The staining of collagen fibrin in rat liver was observed. The protein expression of α-smooth muscle actin (α-SMA),microtubule-associated protein 1 light chain 3(LC3)and p 62 as well as the phosphorylation level of phosphoinositide 3 kinase(PI3K),protein kinase B (Akt)and mammalian target of rapamycin (mTOR)in liver tissue were determined ;mRNA expression corresponding to above protein were also determined. RESULTS :Compared with normal control group ,the hepatic index ,the serum levels of AST ,ALT,HA and Hyp ,the percentage of positive staining area for collagen fibrin ,the mRNA and protein expression of α-SMA and LC 3- Ⅱ were increased significantly (P<0.05). Protein expression of p 62,phosphorylation levels of PI 3K,Akt and mTOR as well as mRNA expression of p 62,PI3K,Akt and mTOR were significantly down-regulated (P<0.05). Compared with model group ,phosphorylation levels of PI 3K and mTOR were decreased significantly in chelidonine low-dose group (P<0.05). The changes of above indexes in chelidonine middle-dose and high-dose groups (except for liver index , HA level in middle-dose group ) were reversed significantly (P<0.05). CONCLUSIONS:Chelidonine can attenuate CCl 4-induced liver fibrosis in rats ;the mechanism of it may be associated with activating PI 3K/Akt/mTOR signaling pathway and inhibiting autophagy.
5.A cross-sectional survey of performance of chemotherapy for echinococcosis in Xinjiang Uygur autonomous region
Haitao LI ; Tao SONG ; Yingmei SHAO ; Wenbao ZHANG ; Hao WEN
Chinese Journal of Epidemiology 2015;36(9):1002-1004
Objective To understand the performance of echinococcosis chemotherapy in echinococcosis endemic areas in Xinjiang Uygur autonomous region (Xinjiang).Methods A questionnaire survey was conducted in the First Affiliated Hospital of Xinjiang Medical University,Hoboksar Mongolia autonomous county,Ermin and Yumin counties from April to June in 2013.Results A total of 329 echinococcosis patients were surveyed,and chemotherapy was provided according to WHO echinococcosis treatment recommendation,the standard treatment rate was and non-standardized medication was 49.2% (162/329) and 50.8% (167/329),respectively.Conclusion It is necessary to standardize the chemotherapy of echinococcosis in some echinococcosis endemic areas in Xinjiang.The comprehensive prevention and treatment include standardized diagnosis,surgical treatment and chemotherapy as well as follow up for individualized treatment.